Propranolol Hydrochloride Patent Expiration
Propranolol Hydrochloride is used for treating hemangioma, including infantile hemangioma. It was first introduced by Wyeth Pharmaceuticals Llc
Propranolol Hydrochloride Patents
Given below is the list of patents protecting Propranolol Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Hemangeol | US8338489 | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas | Oct 16, 2028 | Pierre Fabre |
| Hemangeol | US8987262 | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas | Oct 16, 2028 | Pierre Fabre |
| Innopran Xl | US6500454 | Timed, sustained release systems for propranolol |
Oct 04, 2021
(Expired) | Ani Pharms |
Propranolol Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List